Highmark Commercial Medical Policy - Pennsylvania


 
Printer Friendly Version

Medical Policy: E-34-021
Topic: Respiratory Assist Devices
Section: Durable Medical Equipment
Effective Date: September 11, 2017
Issue Date: September 11, 2017
Last Reviewed: June 2017

A noninvasive positive pressure respiratory assistance (NPPRA) is the administration of positive air pressure, using a nasal and/or oral mask interface which creates a seal, avoiding the use of more invasive airway access (e.g. tracheostomy). 

A respiratory assist device (RAD) without backup rate delivers adjustable, variable levels (within a single respiratory cycle) of positive air pressure by way of tubing and a noninvasive interface (such as a nasal or oral facial mask) to assist spontaneous respiratory efforts and supplement the volume of inspired air into the lungs.

A respiratory assist device (RAD) with backup rate delivers adjustable, variable levels (within a single respiratory cycle) of positive air pressure by way of tubing and a noninvasive interface (such as a nasal or oral facial mask) to assist spontaneous respiratory efforts and supplement the volume of inspired air into the lungs.

This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Policy Position Coverage is subject to the specific terms of the member’s benefit plan.

A respiratory assist device (RAD) may be considered medically necessary for the first three months of therapy for those patients with Restrictive Thoracic Disorders that meet the following criteria:

  • Patient has presence of a neuromuscular disease (e.g., amyotrophic lateral sclerosis) or a severe thoracic cage abnormality (e.g., post-thoracoplasty for TB); and
    • An arterial blood gas PaCO2, done while awake and breathing the patient's prescribed FIO2, is greater than or equal to 45 mm Hg; or
    • Sleep oximetry demonstrates oxygen saturation level is equal to or less than 88% for at least five minutes, done while breathing the patient’s prescribed fractional concentration of oxygen delivered for inspiration (FIO2); or
  • Patient has presence of neuromuscular disease (only):
    • maximal inspiratory pressure is less than 60 cm H2O or forced vital capacity is less than 50% predicted; and
    • Chronic obstructive pulmonary disease does not contribute significantly to the patient's pulmonary limitation.
Procedure Codes
E0470, E0471



A respiratory assist device (RAD) may be considered medically necessary for the first three months of therapy for those patients with Severe COPD that meet ALL of the following criteria:

  • An arterial blood gas PaCO2, done while awake and breathing the patient's prescribed FIO2, is equal to or greater than 52 mm Hg; and
  • Sleep oximetry demonstrates oxygen saturation level equal to or less than 88% for at least five minutes, done while breathing oxygen at two LPM or the patient's prescribed FIO2,whichever is higher; and
  • Prior to initiating therapy, obstructive sleep apnea (OSA) and treatment with CPAP has been considered and ruled out.

If a respiratory assist device (RAD) with backup rate is billed, but the criteria for a respiratory assist device (RAD) without backup rate device are met, payment will be based on the RAD without backup rate.

A RAD with backup rate device will be considered not medically necessary for a patient with COPD during the first two months. Therapy with a RAD without back-up device with proper adjustments of the settings, and patient accommodation to its use, will usually result in sufficient improvement without need of a back-up rate.

Following 61 days of use of a RAD without back-up device; the following criteria may be considered medically necessary when establishing the need for a RAD with back-up device:

  • An arterial blood gas PaCO2 is repeated while the patient is awake and breathing their prescribed FIO2 and the level remains 52 mm HG; and
  • A sleep oximetry, while the patient is breathing with the RAD without back-up device demonstrates O2 saturation of less than 88% for at least five continuous minutes, done while breathing oxygen at two LPM or the patient's prescribed FIO2, whichever is higher.
Procedure Codes
A4604, A7027, A7028, A7029, A7030, A7031, A7032, A7033, A7034, A7035, A7036, A7037, A7038, A7039, A7046, A7044, S8186, A7045, E0470, E0471



A respiratory assist device (RAD) may be considered medically necessary for the first three months of therapy for those patients with Central Sleep Apnea that have had an attended polysomnogram, performed on stationary equipment and meet ALL of the following criteria:

  • The diagnosis of central sleep apnea (CSA); and
  • The exclusion of obstructive sleep apnea (OSA) as the predominant cause of sleep-associated hypoventilation; and
  • The ruling out of CPAP as effective therapy if OSA is a component of the sleep-associated hypoventilation; and
  • Significant improvement of the sleep-associated hypoventilation with the use of either RAD device on the settings that will be prescribed for initial use at home, while breathing the patient's prescribed FIO2.
Procedure Codes
A4604, A7027, A7028, A7029, A7030, A7031, A7032, A7033, A7034, A7035, A7036, A7037, A7038, A7039, A7046, A7044, S8186, A7045, E0470, E0471



Heated and non-heated humidification is covered for use with a medically necessary respiratory assist device when prescribed by the treating physician to meet the needs of the individual patient.

Procedure Codes
E0561, E0562



If the above criteria are not met, the device and related accessories (see table attachment) will be denied as not medically necessary

For coverage beyond the initial three months of therapy, medical necessity of continued coverage of these devices must occur within 61 to 90 days from the date the therapy was initiated.

Quantities of supplies greater than those described in the policy, as the usual maximum amounts will be considered not medically necessary.

A physician must prescribe all equipment and accessory durable medical equipment. 

See Table Attachment for accessory quantity level limits.



For the purpose of this policy, arterial blood gas, sleep oximetry and polysomnographic studies may not be performed by a DME supplier. A DME supplier is not considered a qualified provider or supplier of these tests for purposes of this policy's coverage and payment guidelines. This prohibition does not extend to the results of studies conducted by hospitals certified to do such tests.

See Medical Policy E-20 Devices Used for the Treatment of Obstructive Sleep Apnea in Adults for additional information.


Place of Service: Inpatient/Outpatient

The use of a respiratory assist device is typically an outpatient procedure which is only eligible for coverage as an inpatient procedure in special circumstances, including, but not limited to, the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.


The policy position applies to all commercial lines of business


Denial Statements

Services that do not meet the criteria of this policy will not be considered medically necessary. A network provider cannot bill the member for the denied service unless: (a) the provider has given advance written notice, informing the member that the service may be deemed not medically necessary; (b) the member is provided with an estimate of the cost; and (c) the member agrees in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.

Quantity level limits or quantity of supplies that exceed the frequency guidelines listed on the policy will be denied as non-covered. A network provider cannot bill the member for the non-covered service.

A network provider can bill the member for the non-covered service.

Links





Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect Highmark's reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.

Discrimination is Against the Law
The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:
  • Provides free aids and services to people with disabilities to communicate effectively with us, such as:
    • Qualified sign language interpreters
    • Written information in other formats (large print, audio, accessible electronic formats, other formats)
  • Provides free language services to people whose primary language is not English, such as:
    • Qualified interpreters
    • Information written in other languages
If you need these services, contact the Civil Rights Coordinator.

If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295, TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.

You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:

U.S. Department of Health and Human Services
200 Independence Avenue, SW
Room 509F, HHH Building
Washington, D.C. 20201
1-800-368-1019, 800-537-7697 (TDD)

Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.

Insurance or benefit/claims administration may be provided by Highmark, Highmark Choice Company, Highmark Coverage Advantage, Highmark Health Insurance Company, First Priority Life Insurance Company, First Priority Health, Highmark Benefits Group, Highmark Select Resources, Highmark Senior Solutions Company or Highmark Senior Health Company, all of which are independent licensees of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans.

Highmark retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.



back to top